ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) Director Michael Swinford purchased 16,907 shares of the firm’s stock in a transaction on Friday, November 22nd. The shares were acquired at an average price of $1.83 per share, for a total transaction of $30,939.81. Following the purchase, the director now directly owns 43,418 shares of the company’s stock, valued at approximately $79,454.94. This represents a 63.77 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Michael Swinford also recently made the following trade(s):
- On Monday, November 25th, Michael Swinford bought 21,622 shares of ReWalk Robotics stock. The shares were acquired at an average price of $2.03 per share, for a total transaction of $43,892.66.
- On Wednesday, November 20th, Michael Swinford acquired 16,471 shares of ReWalk Robotics stock. The shares were bought at an average cost of $1.84 per share, for a total transaction of $30,306.64.
ReWalk Robotics Stock Up 1.9 %
NASDAQ LFWD opened at $2.10 on Friday. ReWalk Robotics Ltd. has a 1-year low of $1.70 and a 1-year high of $9.10. The company has a 50 day moving average of $2.52 and a 200-day moving average of $3.48.
Institutional Investors Weigh In On ReWalk Robotics
A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP acquired a new position in ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics at the end of the most recent reporting period. Hedge funds and other institutional investors own 26.76% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $13.00 price target on shares of ReWalk Robotics in a research note on Wednesday, November 13th.
Read Our Latest Stock Analysis on LFWD
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Read More
- Five stocks we like better than ReWalk Robotics
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Zeta Global Holdings Insiders Buy Stock After Short-Report
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Stocks That Never Lived Up to the Hype
- What is a Stock Market Index and How Do You Use Them?
- 3 Stocks to Ride the Manufacturing Sector’s Big Comeback
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.